AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

MedPage Today published a weekly roundup of comments from clinicians and researchers on Oct. 25, 2026. The topics ranged from dengue outbreaks and a multiple sclerosis misdiagnosis to menopause treatments and early-stage research; the roundup does not establish new clinical guidance or confirm the findings beyond the source’s descriptions.

MedPage Today published a weekly roundup on Oct. 25, 2026, collecting comments from clinicians and researchers on dengue outbreaks, a multiple sclerosis misdiagnosis, menopause symptoms and several emerging research questions. The brief report is a selection of quotes, not a single study or policy announcement, and its descriptions do not provide enough detail to establish new medical guidance.

Adam Waickman, PhD, of SUNY Upstate Medical University, used the phrase “The cat is out of the bag” while discussing large dengue outbreaks in Florida and warning of possible further spread across the United States. The roundup does not specify outbreak counts, locations within Florida, or a forecast for additional cases.

Other comments addressed questions at different stages of evidence. Christina Chambers, PhD, MPH, of the University of California San Diego, said it remains an open question whether early-life exposure to dupilumab could affect children’s later risk of atopic conditions. MedPage Today described pregnancy exposure data as appearing safe, but the item gives no study design, sample size or detailed results. Separately, a small trial linked psilocybin with lower markers of systemic inflammation and mitochondrial stress in people with Parkinson’s disease, according to the roundup.

The selection also included a comment by Marisa McGinley, DO, of Cleveland Clinic, about actress Christina Applegate’s incorrect multiple sclerosis diagnosis; a report of an exceptionally rare infant case in which a second colon was later found; and a meta-analysis on non-hormonal menopause drugs and sleep disturbances. Angelo Volandes, MD, MPH, of Dartmouth Health, discussed research on a video decision-support tool that increased advance-care-planning documentation among patients nearing kidney failure. The roundup offers no underlying data or detailed methods for these items.

At a glance
recapWhen: Published October 25, 2026
The developmentMedPage Today published its Oct. 25, 2026, roundup of notable comments from clinicians and researchers covering seven medical topics.

A Snapshot of Current Medical Questions

The roundup matters as a compact view of issues clinicians and researchers are discussing, but its entries should not be read as equivalent kinds of evidence. An outbreak warning, an individual diagnostic case, a meta-analysis and a small trial each have different implications and limits. The source provides brief descriptions rather than enough information to compare the strength or reach of the findings.

For readers, the clearest takeaway is that several potentially consequential questions remain unsettled. The dengue comment points to concern about geographic spread, while the dupilumab and psilocybin items describe research questions that need fuller evidence before their implications can be judged. The advance-care-planning work, meanwhile, concerns documentation and patient preferences, not a reported change in kidney-failure treatment.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

Seven Topics Behind the Quotes

The MedPage Today item is a weekly quotation roundup dated Oct. 25, 2026, and labeled as a two-minute read. It gathers comments from professionals associated with universities, hospitals and health systems in the United States and England. The article’s title, “The Cat Is Out of the Bag,” draws on Waickman’s dengue remark, but the piece also covers unrelated clinical and research developments.

Its other entries include a discussion of incorrect MS diagnoses, a rare report of an infant initially thought to have straightforward constipation, and research on non-hormonal drugs for menopause-related sleep disturbance. The source also records Volandes’ point that health records should capture what matters to patients, alongside medical problems. Together, these subjects span public health, diagnosis, treatment research and care planning; the roundup does not present them as a unified finding.

““This is good news for women.””

— JoAnn Manson, MD, MPH, DrPH, of Harvard Medical School

Evidence Details Remain Limited

The roundup does not provide the underlying study citations, sample sizes, effect estimates or methods for most of the research it mentions. It therefore remains unclear how strong or generalizable the reported findings are, including the pregnancy safety data for dupilumab, the menopause-drug analysis and the small psilocybin trial.

The report also gives no dengue case totals or specific forecast behind the warning about further spread. It does not detail the circumstances of the MS misdiagnosis or the infant’s rare condition. The quotes are attributed, but readers cannot assess their full context from the short roundup alone.

Follow the Underlying Reports

The roundup itself does not announce a follow-up date or a single next milestone. Readers seeking more certainty will need the original studies and clinical reporting behind each item, including full methods, results and any limitations stated by the researchers. Public-health updates from relevant authorities would be needed to track dengue activity and assess whether spread changes.

For the research topics, further studies may clarify long-term outcomes after early-life dupilumab exposure and whether the small-trial psilocybin findings hold up in larger samples. The source does not state that such studies are planned or provide timelines, so those questions remain open.

Key Questions

What is “The Cat Is Out of the Bag” article?

It is MedPage Today’s weekly roundup, published Oct. 25, 2026, featuring comments from clinicians and researchers on several medical topics.

Did the roundup report a new dengue case count?

No. It quoted Adam Waickman discussing large outbreaks in Florida and warning about possible spread, but it did not provide case totals or a detailed forecast.

Does the article show that dupilumab exposure changes children’s future allergy risk?

No. Chambers described that as an open question. The roundup says pregnancy exposure appeared safe, but it does not include the data needed to assess the finding.

What did the roundup say about psilocybin and Parkinson’s disease?

It described a small trial linking psilocybin with reduced markers of systemic inflammation and mitochondrial stress. The item does not establish a treatment benefit or provide detailed results.

Did MedPage Today issue new medical recommendations?

No. The article is a quote-based recap, not a clinical guideline or treatment recommendation. Its brief summaries should be checked against the underlying evidence.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

How to Stay Safe From Cyclospora, a Parasite Causing Severe Intestinal Illness

Learn effective measures to prevent Cyclospora, a parasite causing severe intestinal illness, amid recent outbreaks linked to contaminated produce.

Vote For The First Readers’ Choice Workout!

Interest is rising around “Vote for the first Readers’ Choice workout,” but the source does not confirm a vote, organizer or specific event.

A Proposed Rule Would Politicize Medical Research. Scientists Are Not Happy.

A new proposed regulation aims to influence medical research funding, prompting criticism from scientists who say it risks politicizing the field.

Decades-Old Schizophrenia Drug Wins Approval For New Formulation

The FDA approved Teva’s once-monthly subcutaneous olanzapine for adults with schizophrenia, without loading doses or required PDSS monitoring.